Abstract:COVID-19 presents with a plethora of neurological signs and symptoms despite being characterized as a respiratory disease, including seizures, anxiety, depression, amnesia, attention deficits, and alterations in consciousness. The olfactory nerve is widely accepted as the neuroinvasive route by which the etiological agent SARS-CoV-2 enters the brain, but the trigeminal nerve is an often-overlooked additional route. Based on this consensus, we initially conducted a pilot experiment investigating the olfactory nerve route of SARS-CoV-2 neuroinvasion via intranasal inoculation in AC70 human ACE2 transgenic mice. Notably, we found that the trigeminal ganglion is an early and highly efficient site of viral replication, which then rapidly spread widely throughout the brain where neurons were primarily targeted. Despite the extensive viral infection across the brain, obvious evidence of tissue pathology including inflammatory infiltration, glial activation, and apoptotic cell deaths were not consistently observed, albeit inflammatory cytokines were significantly induced. However, the expression levels of different genes related to neuronal function, including the neurotransmitter dopamine pathway as well as synaptic function, and markers of neuronal damage were altered as compared to mock-infected mice. Our findings suggest that the trigeminal nerve can be a neuroinvasive route complementary to the olfactory nerve and that the ensuing neuroinvasion presented a unique neuropathological profile. This study provides insights into potential neuropathogenic mechanisms utilized by coronaviruses.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **To explore the mechanism by which SARS - CoV - 2 invades the central nervous system (CNS) through the trigeminal nerve and the neuropathological features it causes**. Specifically, the research aims to: 1. **Verify whether the trigeminal nerve is an effective route for SARS - CoV - 2 to enter the brain**: Although the olfactory nerve is considered the main neural invasion route, the trigeminal nerve as another potential invasion route has not been fully studied. 2. **Reveal the infection dynamics of SARS - CoV - 2 in the brain**: In particular, the spread speed and infection pattern of the virus in different brain regions, as well as its impact on specific cell types (such as neurons, astrocytes, and microglia). 3. **Evaluate the impact of SARS - CoV - 2 infection on nerve function**: Including whether the virus infection will lead to obvious neuroinflammation or cell death, and how it changes the gene expression related to nerve function. 4. **Provide new insights into the neuroinvasiveness of SARS - CoV - 2**: These insights are helpful for understanding the multiple neurological symptoms that occur after COVID - 19 infection and may provide a basis for the development of new treatment strategies. ### Research Background COVID - 19 is not only manifested as a respiratory disease, but also accompanied by a series of neurological symptoms, such as epilepsy, anxiety, depression, memory loss, attention deficit, etc. Although the olfactory nerve is considered the main route for SARS - CoV - 2 to enter the brain, the trigeminal nerve as another potential invasion route has been rarely studied. Therefore, it is necessary to deeply explore the role of the trigeminal nerve in the neuroinvasion of SARS - CoV - 2. ### Research Methods The researchers used the AC70 human ACE2 transgenic mouse model and simulated the virus infection process by intranasal inoculation of SARS - CoV - 2. They monitored the distribution of the virus at different time points and analyzed the infection dynamics of the virus in the brain and its impact on the host response through techniques such as immunohistochemistry (IHC), immunofluorescence (IF), and real - time quantitative PCR (RT - qPCR). ### Main Findings 1. **The trigeminal nerve is an early and highly efficient virus replication site**: The study shows that the trigeminal ganglion (TG) is highly infected in the early stage of infection and quickly spreads the virus to the entire brain. 2. **Neurons are the main infection targets**: Although there are multiple cell types in the brain, neurons are the cell type most susceptible to SARS - CoV - 2 infection, while astrocytes and microglia are less affected. 3. **Virus infection changes the expression of genes related to nerve function**: Although there are no obvious signs of neuroinflammation or cell death, virus infection still significantly affects the gene expression related to the neurotransmitter dopamine pathway and synaptic function. 4. **Lack of typical histopathological manifestations**: Although a significant up - regulation of pro - inflammatory cytokines was detected, no obvious inflammatory infiltration, glial cell activation or apoptotic cell death was observed. ### Conclusion This study confirms that the trigeminal nerve can be one of the important routes for SARS - CoV - 2 to enter the brain and reveals the unique neuropathological features caused by virus infection. These findings provide a new perspective for understanding the neuroinvasion mechanism of the new coronavirus and may provide theoretical support for future treatment strategies.

Characterizing neuroinvasion and neuropathology of SARS-CoV-2 by using AC70 human ACE2 transgenic mice

Neuroinvasion of SARS-CoV-2 in human and mouse brain

Human Angiotensin-Converting Enzyme 2 Transgenic Mice Infected with SARS-CoV-2 Develop Severe and Fatal Respiratory Disease

The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys

Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms

ACE2 expression in human dorsal root ganglion sensory neurons: implications for SARS-CoV-2 virus-induced neurological effects

Neuroinvasion and neurotropism of severe acute respiratory syndrome coronavirus 2 infection

SARS-CoV-2 Rapidly Infects Peripheral Sensory and Autonomic Neurons, Contributing to Central Nervous System Neuroinvasion before Viremia

ACE2 and SCARF expression in human dorsal root ganglion nociceptors: implications for SARS-CoV-2 virus neurological effects

Upregulation of Neuroinflammation-Associated Genes in the Brain of SARS-CoV-2-Infected Mice

Neuropathogenesis of SARS-CoV-2 infection

Neurological Manifestations of Patients with COVID-19: Potential Routes of SARS-CoV-2 Neuroinvasion from the Periphery to the Brain

Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models

The Abundant Distribution and Duplication of SARS-CoV-2 in the Cerebrum and Lungs Promote a High Mortality Rate in Transgenic hACE2-C57 Mice

Elimination of olfactory sensory neurons by zinc sulfate inoculation prevents SARS-CoV-2 infection of the brain in K18-hACE2 transgenic mice

Single-cell sequencing of brain tissues reveal the central nervous system's susceptibility to SARS-CoV-2 and the drug

Neurological complications and infection mechanism of SARS-CoV-2

SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model

Pericytes may facilitate SARS-CoV-2 entry into the nervous system

The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains

Inflammatory Response and Defects on Myelin Integrity in the Olfactory System of K18hACE2 Mice Infected with SARS-CoV-2